11:25 AM New York – Acura Pharma was awarded a patent by the U.S. Patent Office. Franklin Covey second quarter net surged 37% and GenCorp second quarter net swung to loss. NII agreed to sell its Peruvian operations for $400 million. WD-40 net in the second quarter slipped.
Acura Pharmaceuticals, Inc
climbed 6.3% or 13 cents to $2.19 after the biotechnology had been awarded a patent by the U.S. Patent and Trademark Office for water soluble drug of abuse and certain opioid products developed by the company.
Franklin Covey Co.
) slipped 2.3% or 33 cents to $13.99 after the consulting services provider reported net sales in the second quarter ending on March 2 climbed 5% to $40.4 million. Net income in the quarter surged 37% to $1.59 million or 8 cents a diluted share compared to $1.16 million or 6 cents.
) slid 2 cents to $13.81 after the aerospace and defense products maker said total revenues in the second quarter ending on February 28 soared 20.7% to $243.7 million. In the quarter net loss swung to $14 million or 24 cents a diluted share compared to net income of $2.4 million or 4 cents.
The company''s order backlog as on February 28 was $1.56 billion from $1.53 billion in quarter ended in November.
NII Holdings, Inc.
) surged 15.4% or 70 cents to $5.24 after the communication service provider agreed to sell its Peruvian operations the indirect subsidiary, Nextel del Peru S.A. to Empresa Nacional de Telecomunicaciones S.A. for nearly $400 million.
) gained 1.5% or 82 cents to $53.64 after the chemical products maker stated total revenues in the second quarter ending on February 28 increased 1% to $86.7 million. Net income in the quarter slipped 1% to $10.46 million or 66 cents a diluted share compared to $10.58 million or 65 cents.
The company added gross profit in the quarter jumped 5% to $44 million.
For the fiscal year 2013, the company expects net sales between $356 million and $370 million and net income in the range of $36.5 million to $38.0 million and diluted earnings per share in the range of $2.32 to $2.42.
) jumped 4.2% or 45 cents to $10.98 after the UK based device maker said total revenues in the first quarter ending on February 28 plunged 34% to $195.6 million. In the quarter net loss swung to $5.14 million or 19 cents a diluted share compared to $10.9 million or 38 cents.
The company added gross profit in the quarter dropped 30% to $36.9 million.
The Xyratex expects revenue for the second quarter in the range of $190 million to $220 million and diluted earnings per share between a loss of 21 cents and earnings of 3 cents.